AstraZeneca and Sanofi have secured approval in the EU for Beyfortus, the first single-dose drug to protect newborns and infants from respiratory syncytial virus (RSV) infections. The antibody-based ...
Immunization with the long-acting monoclonal antibody nirsevimab may provide stronger protection against hospitalizations for ...
Respiratory syncytial virus (RSV) is a common virus that can cause severe respiratory illness in infants and young children, including lower respiratory tract infections (LRTIs) such as bronchiolitis ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Modeling Shows Adoption of New Access MeMed BV Assay Could Cut up to €80M in Avoidable Costs across European Health Systems through Fewer Unnecessary Admissions and Testing BREA, Calif., April 13, ...
Objectives To characterise intrinsic and extrinsic (climatic) risks for mild and severe exertional heat illness (EHI) among first-year army enlistees. Methods We examined 337 786 soldiers who enlisted ...
Infants given the monoclonal antibody nirsevimab, which provides temporary immunity to respiratory syncytial virus (RSV), had lower risks of related hospitalizations and severe outcomes than those ...
Lower respiratory tract infections are diagnostically challenging, particularly since clinical symptoms often overlap with noninfectious causes of acute respiratory failure. A diagnostic model ...
Hosted on MSN
Death toll in Lisbon funicular crash rises to 17
The death toll in the Lisbon funicular crash has risen to 17, an emergency services official said Thursday. Two of the injured died overnight in a hospital, Margarida Castro Martins, head of Lisbon’s ...
Please provide your email address to receive an email when new articles are posted on . The FDA halted enrollment of young children in RSV vaccine trials after five infants in one study developed ...
Tool included 19 variables and had good predictive accuracy, identifying those who did not qualify for palivizumab. HealthDay News — A personalized tool can predict infants at increased risk for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results